Immunoglobulin
Contents
Description
Intravenous immunoglobulin (IVIG) provides passive immunity through pooled antibodies from healthy donors. It is used as supportive therapy in severe combined immunodeficiency and other primary immunodeficiencies to prevent infections while awaiting definitive treatment. IVIG is also used in autoimmune encephalitis including non-paraneoplastic limbic encephalitis as an immunomodulatory agent.
Indications & Therapeutic Use
Primary immunodeficiency, autoimmune encephalitis, chronic inflammatory demyelinating polyneuropathy, immune thrombocytopenia
Global Availability (10 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Immunoglobulin — GNH India
8 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Browse all Immunoglobulin products on GNH IndiaProducts and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
| Generic Name | Immunoglobulin |
| Brands | 1 brand available |
| Active Ingredient | Immune globulin intravenous (human) |
| Drug Class | Primary immunodeficiency |
| Manufacturer | Takeda |
| Dosage Forms | IV infusion 10% solution (100mg/mL), subcutaneous injection 20% solution |
| Medical Code | J06BA02 |
| Orphan Status | No |
| Cold Chain | Required |
| Lead Time | 10 days |
| Reg. Status | FDA Approved |
| Countries | 10 countries |